PharmTech News

Articles

GSK reports no employee injuries at the facility and is assessing damage.

GSK Factory in Tianjin Affected by Explosion

The company is in discussions with Europe’s Adaptive Pathways Group on clinical trials that would evaluate its PLX cells for the treatment of specific diseases.

Pluristem's PLX Cell Therapy Considered for Accelerated Development

Licenses could potentially bring antibody R&D to areas beyond oncology, such as diabetes treatments.

Novo Nordisk Licenses Genmab's Bispecific Antibody Platform

The expansion will enable relocation of its North American headquarters from Grayslake, Illinois.

Xellia Pharmaceuticals Expands Raleigh Site as New North American Headquarters

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Following a divestiture of certain assets in Europe, the acquisition of Sigma-Aldrich by Merck KGaA will be complete.

Merck KGaA’s Acquisition of Sigma-Aldrich Approved by Anti-Trust Regulators

The Biosimilars Forum, along with numerous House members, advocated for the use of unique J-codes for biosimilars in a recent letter to CMS.

Regulators Call for the Revision of Part B Reimbursement Rules for Biosimilars

Deal includes rights to Inovio’s INO-3112 HPV cancer vaccine and preclinical collaboration to develop additional cancer vaccine candidates.

Medimmune and Inovio Pharmaceuticals Form Cancer Pact

Flexion will have a dedicated manufacturing suite at Patheon's Swindon, England facility for Flexion's osteoarthritis steroid drug product.

Flexion Collaborates with Patheon to Manufacture Osteoarthritis Treatment

US generics manufacturer Amneal acquires a former J&J plant in Ireland.

Amneal Purchases Manufacturing Site in Ireland

The agreement gives Merck a non-exclusive license to use Codexis’ proprietary CodeEvolver protein engineering platform technology to develop novel enzymes for use in the manufacture of Merck’s pharmaceutical products.

Bio/Pharma News